Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 286,428 | 238,816 | 10,547 | N/A | N/A |
| Marketable Securities | 238,784 | N/A | N/A | N/A | N/A |
| TOTAL | $530,823 | $243,847 | $12,397 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 31,381 | 19,412 | 9,797 | N/A | N/A |
| Investments And Advances | 16,119 | 0 | 0 | 0 | 0 |
| TOTAL | $47,500 | $19,412 | $9,797 | $N/A | $N/A |
| Total Assets | $578,323 | $263,259 | $22,195 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,703 | 1,739 | 3,597 | 0 | 0 |
| Accrued Expenses | 19,095 | 5,991 | 1,479 | N/A | N/A |
| TOTAL | $79,738 | $7,980 | $5,164 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 23,242 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,452 | 0 | 3,551 | 0 | 0 |
| TOTAL | $11,631 | $66 | $3,551 | $N/A | $N/A |
| Total Liabilities | $91,369 | $8,046 | $8,714 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 105,683 | 90,122 | N/A | N/A | N/A |
| Common Shares | 11 | 9 | 6 | N/A | N/A |
| Retained earnings | 39,009 | -59,285 | -13,382 | N/A | N/A |
| Other shareholders' equity | -457 | 0 | 0 | 0 | 0 |
| TOTAL | $486,954 | $255,213 | $13,480 | $N/A | $N/A |
| Total Liabilities And Equity | $578,323 | $263,259 | $22,195 | $0 | $0 |